消化器内科学
論文
A 欧文A-a
1. Ito H, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, Hoteya S, Nakagawa M, Hatta W, Hirano M, Esaki M,Matsuda M, Ohnita K, Shimoda R, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Hayashi Y, Nakaya N,
Nakamura T, Shimosegawa T: Long-term oncological outcomes of submucosal manipulation during non-curative endoscopic
submucosal dissection for submucosal invasive gastric cancer: a multicenter retrospective study in Japan. Surg Endosc 32(1):196-203, 2018 (IF: 3.117) ＊2. Fukuda M, Okumura M, Iwakiri T, Arimori K, Honda T, Kobayashi K, Senju H, Takemoto S, Ikeda T, Yamaguchi H, NakatomiK, Matsuo N, Mukae H, Ashizawa K: Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related
toxicities in patients with lung cancer. Thorac Cancer 9(1): 51-58, 2018 (IF: 2.569) ＊3. Tag-Adeen M, Hashiguchi K, Akazawa Y, Ohnita K, Yasushi S, Daisuke N, Nakao K: An unusual presentation of adult T-cellleukemia/lymphoma. Ecancermedicalscience 12: 801, 2018
4. Umeda M, Ichinose K, Nishino A, Okada A, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Minami H,Kinoshita N, Takeshima F, Kawakami A: Increased expression of vascular endothelial growth factor in a case of protein-losing
enteropathy with undifferentiated connective tissue disease. Int J Rheum Dis 21(2): 566-570, 2018 (IF: 2.423) ＊5. Mine S, Ozawa E, Ohnita K, Abe K, Nakao K: A case of IgG4-related disease presenting with multiple gastric submucosal
tumors. Gastrointest Endosc 87(2): 608-610, 2018 (IF: 7.204) ＊6. Miyaaki H, Miuma S, Taura N, Shibata H, Soyama A, Hidaka M, Takatsuki M, Eguchi S, Nakao K: PNPLA3 as a liver steatosis
risk factor following living-donor liver transplantation for hepatitis C. Hepatol Res 48(3): E335-E339, 2018 (IF: 3.418) ＊◇7. Ichikawa T, Miyaaki H, Miuma S, Taura N, Motoyoshi Y, Akahoshi H, Nakamura S, Nakamura J, Takahashi Y, Honda T,Yajima H, Uehara R, Hino N, Narita S, Tanaka H, Sasaki S, Nakao K: Hepatitis C virus-related symptoms, but not quality of life,
were improved by treatment with direct-acting antivirals. Hepatol Res 48(3): E232-E239, 2018 (IF: 3.418) ＊8. Mine S, Takeshima F, Akazawa Y, Matsushima K, Minami H, Yamaguchi N, Ohnita K, Isomoto H, Nakao K: Correlation ofFecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Digestion 97(1): 82-89, 2018 (IF: 2.037) ＊○9. Senoo T, Sasaki R, Akazawa Y, Ichikawa T, Miuma S, Miyaaki H, Taura N, Nakao K: Geranylgeranylacetone attenuates
fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon
tetrachloride-treated mice. BMC Gastroenterol 18(1): 34, 2018 (IF: 2.731) ＊★
10. Miuma S, Hidaka M, Takatsuki M, Natsuda K, Soyama A, Miyaaki H, Kanda Y, Tamada Y, Shibata H, Ozawa E, Taura N,Eguchi S, Nakao K: Current characteristics of hemophilia patients co-infected with HIV/HCV in Japan. Exp Ther Med 15(2):2148-2155, 2018 (IF: 1.41) ＊◇11. Sasaki R, Taura N, Miyazoe Y, Yamamichi S, Nakashiki S, Yamashima M, Suehiro T, Honda T, Shibata H, Ozawa E, Miuma S,Akazawa Y, Miyaaki H, Matsumoto T, Nakao K, Ashizawa K: Ketone bodies as a predictor of prognosis of hepatocellular
carcinoma after transcatheter arterial chemoembolization. Nutrition 50: 97-103, 2018 (IF: 3.734) ＊12. Ueda N, Isomoto H, Ikebuchi Y, Kurumi H, Kawaguchi K, Yashima K, Ueki M, Matsushima K, Akashi T, Uehara R, Takeshima
F, Hayashi T, Nakao K: Endocytoscopic classification can be predictive for relapse in ulcerative colitis. Medicine 97(10): e0107,
2018 (IF: 2.028) ＊13. Otsubo R, Mussazhanova Z, Akazawa Y, Sato A, Matsuda K, Matsumoto M, Yano H, Matsuse M, Mitsutake N, Ando T, Niino
D, Nagayasu T, Nakashima M: Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a
7-year-old Japanese girl: a case report and review of literature. J Pediatr Endocrinol Metab 31(4): 461-467, 2018 (IF: 1.086) ＊14. Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M,Ohnita K, Yamanouchi K, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Hayashi Y, Nakamura T, Nakaya
N, Shimosegawa T: Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic
submucosal dissection for early gastric cancer? A comparative study. Gastric Cancer 21(3): 481-489, 2018 (IF: 5.045) ＊15. Kurumi H, Kanda T, Kawaguchi K, Yashima K, Koda H, Ogihara K, Matsushima K, Nakao K, Saito H, Fujiwara Y, Osaki M,Okada F, Isomoto H: Protoporphyrinogen oxidase is involved in the fluorescence intensity of 5-aminolevulinic acid-mediatedlaser-based photodynamic endoscopic diagnosis for early gastric cancer. Photodiagnosis Photodyn Ther 22: 79-85, 2018 (IF:2.895) ＊16. Miyahara K, Hatta W, Nakagawa M, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, Hoteya S, Hirano M, Esaki M, Matsuda
M, Ohnita K, Shimoda R, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Aoyagi H, Shimosegawa T: The
Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal

1Dissection for Early Gastric Cancer. Digestion 98(3): 161-168, 2018 (IF: 2.037) ＊17. Matsuzaki T, Eguchi K, Nagao N, Tsuji S, Aramaki T, Terada K, Iwatsu S, Tokimura I, Kamo Y, Oda H, Kinoshita N, Miyaaki
H, Taura N, Ichikawa T, Kawakami A, Nakao K, Ueki Y: Hepatitis B virus reactivation in patients with rheumatoid arthritis: A
single-center study. Mod Rheumatol 28(5): 808-813, 2018 (IF: 1.955) ＊18. Makiyama A, Kunieda K, Noguchi M, Kajiwara T, Tamura T, Takeda K, Sugiyama J, Minashi K, Moriwaki T, Sugimoto N,Nagase M, Negoro Y, Tsuda T, Shimodaira H, Okano N, Tsuji A, Sakai D, Yanagihara K, Ueda S, Tamura S, Otsu S, Honda T,Matsushita Y, Okuno T, Kashiwada T, Nozaki A, Ebi M, Okuda H, Shimokawa M, Hironaka S, Hyodo I, Baba E, Boku N, Muro
K, Esaki T: First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: amulticenter propensity score matched study. Gastric Cancer 21(5): 792-801, 2018 (IF: 5.045) ＊19. Suehiro T, Miyaaki H, Kanda Y, Shibata H, Honda T, Ozawa E, Miuma S, Taura N, Nakao K: Serum exosomal microRNA-122
and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patients. Oncol
Lett 16(3): 3267-3273, 2018 (IF: 1.664) ＊○20. Fukushima M, Dasgupta D, Mauer AS, Kakazu E, Nakao K, Malhi H: StAR-related lipid transfer domain 11 (STARD11)mediated ceramide transport mediates extracellular vesicle biogenesis. J Biol Chem 293(39): 15277-15289, 2018 (IF: 4.011) ＊21. Matsuda K, Kawasaki T, Akazawa Y, Hasegawa Y, Kondo H, Suzuki K, Iseki M, Nakashima M: Expression pattern of
p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma. Sci Rep 8(1): 15477,2018 (IF: 4.122) ＊22. Miuma S, Miyaaki H, Soyama A, Hidaka M, Takatsuki M, Shibata H, Taura N, Eguchi S, Nakao K: Utilization and efficacy ofelbasvir/grazoprevir for treating hepatitis C virus infection after liver transplantation. Hepatol Res 48(12): 1045-1054, 2018 (IF:3.418) ＊23. Yamashima M, Ozawa E, Ohnita K, Tabata K, Natsuda K, Ono S, Hidaka M, Eguchi S, Nakao K: Hepatobiliary and Pancreatic:
Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease. J Gastroenterol Hepatol 33(11): 1821, 2018(IF: 3.483) ＊24. Miuma S, Miyaaki H, Miyazoe Y, Suehiro T, Sasaki R, Shibata H, Taura N, Nakao K: Development of Duodenal Ulcers due tothe Discontinuation of Proton Pump Inhibitors After the Induction of Sofosbuvir Plus Ledipasvir Therapy: A Report of TwoCases. Transplant Proc 50(1): 222-225, 2018 (IF: 0.806) ＊25. Iwasa M, Karino Y, Kawaguchi T, Nakanishi H, Miyaaki H, Shiraki M, Nakajima T, Sawada Y, Yoshiji H, Okita K, Koike K:
Relationship of muscle cramps to quality of life and sleep disturbance in patients with chronic liver diseases: a nationwide study.
Liver Int 38(12): 2309-2316, 2018 (IF: 4.5) ＊26. Tag-Adeen M, Ozawa E, Ogihara K, Iwatsu S, Akazawa Y, Ohnita K, Adachi T, Sumida Y, Nakao K: The role of pancreatic
juice cytology in the diagnosis of pancreatic intraductal papillary mucinous neoplasm. Rev Esp Enferm Dig 110(12): 775-781,
2018 (IF: 1.632) ＊A-b
1. Akazawa Y, Nakao K: To die or not to die: death signaling in nonalcoholic fatty liver disease. J Gastroenterol 53(8): 893-906,
2018 (IF: 5.561) ＊B 邦文
B-a
1. 廣瀬弥幸, 井上公介, 國廣 遵, 森田知之, 秋山久美子, 松浦はるみ, 赤澤祐子, 長谷川ゆり：維持血液透析導入症例における疾患特異的な診療記録の質的監査．診療情報管理 29(4): 25-30, 2018
2. 加茂泰広, 田島和昌, 小田英俊, 木下 昇, 富永雅也, 山本美保子, 米満伸久, 竹島史直, 中尾一彦：サイトメガロウイ
ルス腸炎後に生じた大腸狭窄に対し内視鏡的バルーン拡張術を施行した 1 例．Gastroenterological Endoscopy 60(6):1219-1224, 2018
3. 田渕真惟子, 荻原久美, 南 ひとみ, 赤澤祐子, 松尾 諭, 坂口功一, 藤山大祐, 山口直之, 竹島史直, 中尾一彦：急速に増大した下咽頭癌に対して全身麻酔下咽頭 ESD を施行した 1 例．長崎医学会雑誌 93(1): 30-36, 2018
4. 小澤栄介, 岩津伸一, 澤瀬寛典, 小松直広, 大仁田 賢, 山尾拓史, 中尾一彦：当院における内視鏡的十二指腸乳頭切除術の治療成績．長崎医学会雑誌 93(3): 189-196, 20185. 日野直之, 岩津伸一, 中鋪 卓, 成田翔平, 原口雅史, 佐々木 龍, 本田琢也, 柴田英貴, 三馬 聡, 小澤栄介, 宮明寿
光, 三浦史郎, 秋葉 純, 中尾一彦：大腸癌, 転移性肝腫瘍, 転移性肺腫瘍に対してレゴラフェニブを投与し急性肝不全を認めた 1 例．The LIVER CANCER JOURNAL 10(2): 81-82, 2018B-b
1. 小澤栄介, 中尾一彦：中心静脈栄養法．臨牀と研究 95(8): 876-879, 201822. 南 ひとみ, 磯本
1328-1334, 2018一, 山口直之, 大仁田賢, 竹島史直, 中尾一彦, 井上晴洋：IVBC の再考．胃と腸 53(10):

3. 小松直広, 潟沼朗生, 小澤栄介, 中尾一彦：十二指腸乳頭部腫瘍の局所進展度診断と治療．消化器外科 41(10):1393-1402, 2018

B-d
1. 三馬 聡, 中尾一彦：肝移植後 HCV 再発に対する治療．Best Practice(血液製剤による HIV/HCV 重複感染者に対する肝移植のベストプラクティス 2018), 平成 29 年度厚生労働科学研究費補助金 エイズ対策研究事業 血液製剤によるHIV/HCV 重複感染者の肝移植に関する研究 分担研究報告, pp.46-51, 2018

教 室 等 名 ： 303 消 化 器 内 科

研究業績集計表
論文数一覧
2018A-aA-bA-cA-dA-e

合計

SCI

B-aB-bB-cB-dB-e

合計

総計2610002726

53010936

合計

総計

121

140

学会発表数一覧
A-a2018

合計

A-bｼﾝﾎﾟｼﾞｳﾑ

学会

014

519B-aB-bｼﾝﾎﾟｼﾞｳﾑ

学会

1998

4

論文総数に係る教員生産係数一覧

2018

欧文論文総数
論文総数

教員生産係数（欧文論文）

SCI掲載論文数
欧文論文総数

教員生産係数（SCI掲載論文）

0.75

3

0.963

2.889

Impact factor 値一覧
2018

Impact factor

教員当たり Impact factor

論文当たり Impact factor

81.3499.039

3.1293